British Business Bank commits £140M to Advent Life Sciences funds

What's the deal? The British Business Bank has agreed to back two Advent Life SciencesDealroom has a profile for this one. Try Dealroom → funds with up to £135 million, part of an ongoing push into the sector. The commitment lifts the state-owned bank's total life sciences backing to nearly £750 million.

What's the endgame? Advent Life Sciences invests in early-stage biotech and healthcare companies. The fresh commitment gives it more firepower to deploy across new and existing funds.

Why now? The British Business Bank is expanding its footprint in life sciences, a sector the UK government has flagged as a priority for economic growth. The Advent commitment adds to a growing pipeline of similar backing.

The signal: With state-backed money flowing toward specialist life sciences managers, the UK is betting on its research base to anchor domestic biotech. Advent's funds are among the vehicles it is using to place that bet.

Read more: altassets.net

Image credit: Generated with Gemini